“Across the life sciences industry, there is a need to reimagine the drug development process to bring innovative and personalized treatments to market faster without compromising patient safety and data integrity," said Raj Indupuri, CEO of eClinical Solutions.
BOSTON (PRWEB) November 26, 2019
eClinical Solutions LLC, a leading provider of cloud based enterprise software and software-driven clinical data services, is launching the elluminate®️ Engage Conference, a multi-day user event with a focus on how the elluminate platform can help simplify and improve the clinical development process. elluminate Engage is an invite-only conference for clients that will take place December 4-5, 2019, at the Sonesta Hotel in Cambridge, Massachusetts. The conference will feature speakers from across the life-sciences industry including a keynote address from Nandish Poluru, Head of Technology for Global Drug Development Operations, Biometrics and Data Sciences, and Digital Health at Bristol Myers Squibb. Other speakers include:
- David Weigand, Director, Clinical Data Reporting and Analytics, Bristol Myers Squibb
- Manny Lazaro, VP, Head of Clinical Operations, Jounce Therapeutics
- John Keilty, Chief Data Sciences Officer, Decibel Therapeutics
- Beth Harper, Workforce Innovation Officer, Association of Clinical Research Professionals
- Michael Wilkinson, Study Manager, Tufts Center for the Study of Drug Development
- Bob O'Connor, Associate Director, Clinical Data Systems, Agios Pharmaceuticals
- Sean McNiff, Associate Director, Clinical Programming, bluebird bio
The conference keynote will cover the digital health revolution that the life sciences industry is currently experiencing and how a modern technology infrastructure supports key business objectives for digital transformation. Other sessions include best practices for using elluminate applications to improve outcomes in clinical operations, data management, clinical programming and biostatistics. There are numerous collaborative breakout sessions where speakers and attendees will share case studies and best practices, while also providing feedback on new product capabilities, which include the latest version of elluminate Data Central used for comprehensive data review and more automated external data reconciliation. Talks also include preliminary results from an industry survey on data sources and data strategy conducted in conjunction with the Tufts Center for the Study of Drug Development.
“Across the life sciences industry, there is a need to reimagine the drug development process to bring innovative and personalized treatments to market faster without compromising patient safety and data integrity. There are tremendous volumes of data now available for use in research, but gaps in the way data is acquired and analyzed by users responsible for acting on the data,” said Raj Indupuri, CEO of eClinical Solutions. “We are delighted to bring this group of elluminate users together to discuss current trends and best practices, as well as the exciting future ahead.”
For more information on the agenda and speakers for the elluminate Engage Conference, please visit https://go.eclinicalsol.com/Engage2019.
About eClinical Solutions LLC
eClinical Solutions is a leading global provider of cloud based enterprise software and software-driven clinical data services. The elluminate platform provides life sciences companies with greater control of their clinical trial data. elluminate software and data driven services have been used by more than 100 life sciences companies on more than 500 trials. For more information, visit http://www.eclinicalsol.com.